Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DEF8 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
mRNA | CTD-2331H12.8 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
mRNA | ELAVL4 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-06 |
mRNA | CDC42SE1 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
mRNA | MBTD1 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-06 |
mRNA | NFS1 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
mRNA | ARNT | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
mRNA | PARP15 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
mRNA | CCDC14 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
mRNA | TRIM9 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |